Edgemoor Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.94M | Buy |
282,832
+14,902
| +6% | +$397K | 0.62% | 40 |
|
|
2025
Q4 | $6.67M | Buy |
267,930
+13,529
| +5% | +$341K | 0.52% | 42 |
|
|
2025
Q3 | $6.48M | Buy |
254,401
+17,832
| +8% | +$440K | 0.5% | 45 |
|
|
2025
Q2 | $5.73M | Buy |
236,569
+22,996
| +11% | +$536K | 0.5% | 48 |
|
|
2025
Q1 | $5.41M | Buy |
213,573
+194,853
| +1,041% | +$5.1M | 0.5% | 48 |
|
|
2024
Q4 | $497K | Hold |
18,720
| – | – | 0.04% | 119 |
|
|
2024
Q3 | $542K | Hold |
18,720
| – | – | 0.05% | 113 |
|
|
2024
Q2 | $524K | Sell |
18,720
-2,297
| -11% | -$63.2K | 0.05% | 110 |
|
|
2024
Q1 | $583K | Buy |
21,017
+158
| +0.8% | +$4.38K | 0.06% | 106 |
|
|
2023
Q4 | $601K | Sell |
20,859
-822
| -4% | -$24.8K | 0.06% | 106 |
|
|
2023
Q3 | $719K | Hold |
21,681
| – | – | 0.09% | 95 |
|
|
2023
Q2 | $795K | Sell |
21,681
-308
| -1% | -$12K | 0.09% | 93 |
|
|
2023
Q1 | $897K | Sell |
21,989
-5,022
| -19% | -$217K | 0.11% | 87 |
|
|
2022
Q4 | $1.38M | Buy |
27,011
+3,065
| +13% | +$147K | 0.17% | 80 |
|
|
2022
Q3 | $1.05M | Sell |
23,946
-3,857
| -14% | -$187K | 0.14% | 81 |
|
|
2022
Q2 | $1.46M | Buy |
27,803
+195
| +0.7% | +$9.94K | 0.18% | 79 |
|
|
2022
Q1 | $1.43M | Buy |
27,608
+822
| +3% | +$42.6K | 0.15% | 77 |
|
|
2021
Q4 | $1.58M | Hold |
26,786
| – | – | 0.16% | 71 |
|
|
2021
Q3 | $1.15M | Sell |
26,786
-8,325
| -24% | -$369K | 0.13% | 72 |
|
|
2021
Q2 | $1.38M | Buy |
35,111
+1,380
| +4% | +$53.7K | 0.13% | 71 |
|
|
2021
Q1 | $1.22M | Buy |
33,731
+2,828
| +9% | +$100K | 0.12% | 70 |
|
|
2020
Q4 | $1.14M | Sell |
30,903
-4,193
| -12% | -$154K | 0.13% | 70 |
|
|
2020
Q3 | $1.22M | Buy |
35,096
+21,222
| +153% | +$744K | 0.15% | 69 |
|
|
2020
Q2 | $430K | Hold |
13,874
| – | – | 0.06% | 88 |
|
|
2020
Q1 | $430K | Hold |
13,874
| – | – | 0.07% | 85 |
|
|
2019
Q4 | $516K | Hold |
13,874
| – | – | 0.06% | 95 |
|
|
2019
Q3 | $473K | Sell |
13,874
-7,062
| -34% | -$257K | 0.06% | 98 |
|
|
2019
Q2 | $860K | Hold |
20,936
| – | – | 0.11% | 84 |
|
|
2019
Q1 | $844K | Buy |
20,936
+94
| +0.5% | +$3.77K | 0.11% | 82 |
|
|
2018
Q4 | $863K | Buy |
20,842
+649
| +3% | +$26.9K | 0.13% | 82 |
|
|
2018
Q3 | $844K | Sell |
20,193
-316
| -2% | -$12.2K | 0.1% | 84 |
|
|
2018
Q2 | $706K | Sell |
20,509
-579
| -3% | -$19.8K | 0.09% | 88 |
|
|
2018
Q1 | $710K | Sell |
21,088
-5,531
| -21% | -$190K | 0.09% | 90 |
|
|
2017
Q4 | $924K | Sell |
26,619
-772
| -3% | -$26.3K | 0.12% | 81 |
|
|
2017
Q3 | $928K | Hold |
27,391
| – | – | 0.13% | 88 |
|
|
2017
Q2 | $873K | Hold |
27,391
| – | – | 0.12% | 88 |
|
|
2017
Q1 | $889K | Sell |
27,391
-6,176
| -18% | -$195K | 0.13% | 83 |
|
|
2016
Q4 | $1.03M | Buy |
33,567
+7,313
| +28% | +$223K | 0.16% | 75 |
|
|
2016
Q3 | $844K | Hold |
26,254
| – | – | 0.13% | 79 |
|
|
2016
Q2 | $877K | Sell |
26,254
-527
| -2% | -$16.8K | 0.14% | 80 |
|
|
2016
Q1 | $753K | Buy |
26,781
+601
| +2% | +$17.2K | 0.12% | 85 |
|
|
2015
Q4 | $802K | Sell |
26,180
-264
| -1% | -$8.3K | 0.12% | 94 |
|
|
2015
Q3 | $788K | Buy |
26,444
+415
| +2% | +$13.3K | 0.12% | 97 |
|
|
2015
Q2 | $828K | Sell |
26,029
-9,167
| -26% | -$299K | 0.12% | 93 |
|
|
2015
Q1 | $1.16M | Sell |
35,196
-1,351
| -4% | -$43K | 0.16% | 80 |
|
|
2014
Q4 | $1.08M | Sell |
36,547
-1,054
| -3% | -$30.2K | 0.16% | 78 |
|
|
2014
Q3 | $1.05M | Buy |
37,601
+2,278
| +6% | +$63.9K | 0.15% | 84 |
|
|
2014
Q2 | $995K | Sell |
35,323
-419,272
| -92% | -$12M | 0.15% | 87 |
|
|
2014
Q1 | $13.9M | Sell |
454,595
-896
| -0.2% | -$26.7K | 2.19% | 10 |
|
|
2013
Q4 | $13.2M | Sell |
455,491
-3,659
| -0.8% | -$106K | 2.1% | 13 |
|
|
2013
Q3 | $12.5M | Sell |
459,150
-3,204
| -0.7% | -$87.2K | 2.18% | 11 |
|
|
2013
Q2 | $12.3M | Buy |
+462,354
| New | +$12.8M | 2.18% | 13 |
|
Other funds holding PFE
VCM
VPM
Edgemoor Investment Advisors's PFE Position: Q1 2026 in Review
Edgemoor Investment Advisors increased its Pfizer (PFE) stake by 5.6% in Q1 2026, buying an estimated $397K and bringing the position to 282,832 shares worth $7.94M. The position accounts for 0.62% of the portfolio, ranked #40.
Edgemoor Investment Advisors first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.9M in Q1 2014. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Edgemoor Investment Advisors held 282,832 shares of Pfizer worth $7.94M as of Q1 2026.
- Edgemoor Investment Advisors bought 14,902 Pfizer shares in Q1 2026, an estimated $397K.
- Pfizer made up 0.62% of Edgemoor Investment Advisors's portfolio in Q1 2026, its #40 holding.
- Edgemoor Investment Advisors first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Edgemoor Investment Advisors's Pfizer position peaked at $13.9M in Q1 2014.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Edgemoor Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.